GB0913672D0 - Glitazones - Google Patents

Glitazones

Info

Publication number
GB0913672D0
GB0913672D0 GB0913672A GB0913672A GB0913672D0 GB 0913672 D0 GB0913672 D0 GB 0913672D0 GB 0913672 A GB0913672 A GB 0913672A GB 0913672 A GB0913672 A GB 0913672A GB 0913672 D0 GB0913672 D0 GB 0913672D0
Authority
GB
United Kingdom
Prior art keywords
glitazones
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0913672A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pulmagen Therapeutics Inflammation Ltd
Original Assignee
Argenta Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Argenta Discovery Ltd filed Critical Argenta Discovery Ltd
Priority to GB0913672A priority Critical patent/GB0913672D0/en
Publication of GB0913672D0 publication Critical patent/GB0913672D0/en
Priority to PCT/GB2010/051285 priority patent/WO2011015868A1/en
Priority to US12/850,318 priority patent/US8236786B2/en
Priority to US13/537,503 priority patent/US8815837B2/en
Priority to US14/246,695 priority patent/US9078885B2/en
Ceased legal-status Critical Current

Links

GB0913672A 2008-08-07 2009-08-05 Glitazones Ceased GB0913672D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GB0913672A GB0913672D0 (en) 2009-08-05 2009-08-05 Glitazones
PCT/GB2010/051285 WO2011015868A1 (en) 2009-08-05 2010-08-04 Enantiomeric resolution method
US12/850,318 US8236786B2 (en) 2008-08-07 2010-08-04 Respiratory disease treatment
US13/537,503 US8815837B2 (en) 2008-08-07 2012-06-29 Respiratory disease treatment
US14/246,695 US9078885B2 (en) 2008-08-07 2014-04-07 Respiratory disease treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0913672A GB0913672D0 (en) 2009-08-05 2009-08-05 Glitazones

Publications (1)

Publication Number Publication Date
GB0913672D0 true GB0913672D0 (en) 2009-09-16

Family

ID=41129681

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0913672A Ceased GB0913672D0 (en) 2008-08-07 2009-08-05 Glitazones

Country Status (2)

Country Link
GB (1) GB0913672D0 (en)
WO (1) WO2011015868A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012177956A1 (en) * 2011-06-23 2012-12-27 Metabolic Solutions Development Comapny, Llc Ppar-sparing compounds for use in the treatment of diabetes and other metabolic diseases
US20130158077A1 (en) 2011-12-19 2013-06-20 Ares Trading S.A. Pharmaceutical compositions
US9504679B2 (en) 2011-12-19 2016-11-29 Bjoern Colin Kahrs Pharmaceutical compositions comprising glitazones and Nrf2 activators
WO2024157585A1 (en) * 2023-01-24 2024-08-02 株式会社カネカ Method for producing optically active substance

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6204288B1 (en) 1999-03-08 2001-03-20 The University Of Mississippi 1,2-dithiolane derivatives
GB9908647D0 (en) 1999-04-15 1999-06-09 Smithkline Beecham Plc Novel compounds
AU2001288271A1 (en) 2000-08-17 2002-02-25 Harrihar A. Pershadsingh Methods for treating inflammatory diseases
TW200745099A (en) 2006-03-02 2007-12-16 Sankyo Co Optically active thiazolidinedione derivatives
NZ590774A (en) 2008-08-07 2012-09-28 Pulmagen Therapeutics Inflammation Ltd Substantially pure 5R enantiomers of pioglitazone and rosiglitazone for treating inflammatory respiratory diseases

Also Published As

Publication number Publication date
WO2011015868A1 (en) 2011-02-10

Similar Documents

Publication Publication Date Title
DK3023438T3 (en) Anti-gitr-antistoffer
DK2457337T3 (en) Specialtilpasset impuls-burst
EP2462514A4 (en) Greenbooks
EP2515891A4 (en) 3-keto-n-propargyl-1-aminoindan
EP2519921A4 (en) Call-tracking
DK2464943T3 (en) Systemintegration
GB0913672D0 (en) Glitazones
IL208602A0 (en) Mezuzah case
GB0900568D0 (en) Poymerisation
GB0900319D0 (en) Hydrocharger
EP2510125A4 (en) Hyperprimers
AU4925P (en) Bonscawi Scaevola aemula
AU4924P (en) Bonscablue Scaevola aemula
AU4240P (en) Tuckerbox xTriticosecale
TWM372836U (en) Case
GB0905223D0 (en) Case
EG26256A (en) Oxyga
GB0900183D0 (en) Lugg-Scan
GB0900671D0 (en) Tugbug
AU329913S (en) Cupcan
GB0900008D0 (en) Lasha2
GB0900026D0 (en) BodyBreak
GB0900035D0 (en) Mabati-sip
AU324442S (en) Keylight
GB0900201D0 (en) Lasha2A

Legal Events

Date Code Title Description
COOA Change in applicant's name or ownership of the application

Owner name: PULMAGEN THERAPEUTICS (INFLAMMATION) LIMITED

Free format text: FORMER OWNER: ARGENTA DISCOVERY LIMITED

AT Applications terminated before publication under section 16(1)